11
Dyslipidemia CASE 5A

Dyslipidemia

  • Upload
    thora

  • View
    18

  • Download
    2

Embed Size (px)

DESCRIPTION

Dyslipidemia. CASE 5A. Aling D., 62 years old female who came in for a General Check-up. General Data. Pertinent Information. Aling D., 62/F, came in for general check-up Smoker (20-pack years) Frequently eats fatty food Sedentary lifestyle - PowerPoint PPT Presentation

Citation preview

Page 1: Dyslipidemia

Dyslipidemia

CASE 5A

Page 2: Dyslipidemia

Aling D., 62 years old femalewho came in for aGeneral Check-up

General Data

Page 3: Dyslipidemia

Pertinent Information

Aling D., 62/F, came in for general check-up Smoker (20-pack years) Frequently eats fatty food Sedentary lifestyleFather had history of ischemic cerebrovascular

disease and MI at 38 y/o Urinalysis, CBG, EKG returned normal CXR: Atherosclerotic aorta PE: essentially unremarkable

Page 4: Dyslipidemia

Laboratory Results

Parameter Normal Result Interpretation

Total Cholesterol<200 mg/dL;>/=240 mg/dL

considered high280 mg/dL High

LDL

<100 mg/dL optimal

>/=190 mg/dL very high

190 mg/dL High

HDL 40-60 mg/dL 50 mg/dL Normal

Triglycerides <180 mg/dL 145 mg/dL Normal

Page 5: Dyslipidemia

Step 1

Diagnosis and Risk Assessment

Page 6: Dyslipidemia

Diagnosis and Risk Assessment

LOW RISK: < 3 of the following* Hypertension Familial hypercholesterolemia LVH Smoking Family history of CAD Male sex Age > 55 years old Proteinuria Albuminuria BMI ≥ 25

* CPG on Management of Dyslipidemia in the Philippines

Page 7: Dyslipidemia

Diagnosis and Risk Assessment

LOW RISK: < 3 of the following* Hypertension Familial hypercholesterolemia LVH Smoking Family history of CAD Male sex Age > 55 years old Proteinuria Albuminuria BMI ≥ 25

Page 8: Dyslipidemia

Framingham Cardiac Risk Score

Page 9: Dyslipidemia

Primary Working Impression

Dyslipidemia t/c metabolic syndromeAtherosclerosisHigh CV Risk

Page 10: Dyslipidemia

Step 2

Therapeutic Objectives

Page 11: Dyslipidemia

Therapeutic Objectives

1. Lower cholesterol to normal levels pharmacologically

2. Reduce overall risk factors

a. Smoking cessation

b. Manage diet and promote active lifestyle

c. Weight control (depends on his BMI and WHR)

3. Educate patient about medications (dosing, indications, adverse effects, etc.)